Back

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

Xie, X.; Zou, J.; Fontes-Garfias, C. R.; Xia, H.; Swanson, K. A.; Cutler, M.; Cooper, D.; Menachery, V. D.; Weaver, S. D.; Dormitzer, P. R.; Shi, P.-Y.

2021-01-07 microbiology Community evaluation
10.1101/2021.01.07.425740 bioRxiv
Show abstract

Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and South Africa share the spike N501Y substitution, which is of particular concern because it is located in the viral receptor binding site for cell entry and increases binding to the receptor (angiotensin converting enzyme 2). We generated isogenic N501 and Y501 SARS-CoV-2. Sera of 20 participants in a previously reported trial of the mRNA-based COVID-19 vaccine BNT162b2 had equivalent neutralizing titers to the N501 and Y501 viruses.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
New England Journal of Medicine
● 52 papers in training set
Top 0.1%
22.4%
Similar papers in this journal
2
The Lancet Infectious Diseases
○ 73 papers in training set
Top 0.1%
15.1%
Similar papers in this journal
3
Nature Medicine
○ 125 papers in training set
Top 0.1%
9.7%
Similar papers in this journal
4
Nature
○ 645 papers in training set
Top 2%
7.9%
Similar papers in this journal
50% of probability mass above
5
Nature Communications
○ 5641 papers in training set
Top 28%
5.2%
Similar papers in this journal
6
Vaccine
○ 203 papers in training set
Top 0.8%
4.0%
7
Science Translational Medicine
● 127 papers in training set
Top 0.7%
3.2%
8
eBioMedicine
○ 183 papers in training set
Top 1%
2.8%
9
The Journal of Infectious Diseases
◐ 202 papers in training set
Top 1%
2.4%
10
Journal of Infection
○ 78 papers in training set
Top 0.3%
2.4%
11
Cell Reports Medicine
○ 153 papers in training set
Top 1%
2.4%
12
Science
● 477 papers in training set
Top 4%
2.1%
13
Clinical Infectious Diseases
◐ 235 papers in training set
Top 1%
2.1%
14
Nature Microbiology
○ 155 papers in training set
Top 2%
1.9%
15
The Lancet Microbe
○ 44 papers in training set
Top 0.4%
1.7%
16
iScience
○ 1154 papers in training set
Top 26%
1.1%
17
npj Vaccines
○ 67 papers in training set
Top 0.6%
1.1%
18
The Lancet Respiratory Medicine
○ 19 papers in training set
Top 0.2%
1.1%
19
International Journal of Infectious Diseases
○ 129 papers in training set
Top 2%
1.0%
20
PLOS Pathogens
● 820 papers in training set
Top 9%
0.9%
21
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.6%
0.8%
22
The Lancet
○ 16 papers in training set
Top 0.3%
0.6%
23
Cell Reports
○ 1498 papers in training set
Top 29%
0.6%
24
Emerging Microbes & Infections
○ 74 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.